Skip to main content
Caplight Logo









Annogen

Annogen

Private
AmsterdamHealthcare & Life Scienceshttps://annogen.bio/

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Annogen is a biotechnology company that provides gene expression engineering services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Infrastructure

Keywords

gene expression engineeringpromoter discoverySurvey of Regulatory Elementsregulatory element screeningfunctional genomicscell and gene therapyenhancer identificationpromoter engineeringintegration site mappingnon-coding DNA analysiscell line developmentviral vector optimizationagricultural biotechnologyCHO cell line servicescrop engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Annogen Comparables

Compare Annogen with similar companies based on industry and business-model similarity.

Annogen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chromatin Bioscience
84%
SynGenSys
84%
Bayer AG
74%

Annogen Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Joris van Arensbergen

Founder And CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    Monthly visitors grew 284% MoM, from 531 to 2K.

  • Feb 16, 2026

    Grew 50% QoQ from 6 to 9 employees.

Annogen Filings

Explore SEC and related filing metadata, where available.

Annogen filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Annogen's valuation, stock price, and market status.

Is Annogen a public or private company?

Annogen is a private company.

What is the current stock price of Annogen?

Annogen is a private company with no public stock price. No recent secondary market data is available.

How much is Annogen worth (valuation)?

Valuation information for Annogen is not publicly available.

Can I buy Annogen stock?

Annogen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Annogen's last funding round?

Funding round information for Annogen is not publicly available.

Who are the main investors in Annogen?

Investor information for Annogen is not publicly disclosed.

Will Annogen IPO soon?

No public IPO plans have been announced for Annogen.

How can I track Annogen secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Annogen's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAmsterdam
Employee Range10
Year Founded2017
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?